John Christopher Petrozza, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Reproductive Medicine | 7 | 2022 | 99 | 2.880 |
Why?
|
Infertility, Female | 13 | 2024 | 760 | 2.410 |
Why?
|
Hysteroscopy | 4 | 2021 | 62 | 2.060 |
Why?
|
Infertility | 14 | 2023 | 654 | 1.620 |
Why?
|
Insemination, Artificial | 6 | 2016 | 99 | 1.540 |
Why?
|
Gynecology | 2 | 2023 | 526 | 1.130 |
Why?
|
Sterilization, Reproductive | 3 | 2022 | 24 | 1.030 |
Why?
|
Leiomyoma | 5 | 2024 | 636 | 0.980 |
Why?
|
Environmental Pollutants | 10 | 2024 | 1277 | 0.970 |
Why?
|
Uterus | 6 | 2021 | 649 | 0.950 |
Why?
|
Pregnancy, Abdominal | 1 | 2023 | 6 | 0.910 |
Why?
|
Pregnancy Rate | 11 | 2019 | 648 | 0.890 |
Why?
|
Ovulation Induction | 7 | 2016 | 277 | 0.870 |
Why?
|
Mullerian Ducts | 3 | 2021 | 203 | 0.870 |
Why?
|
Sterilization, Tubal | 2 | 2022 | 75 | 0.860 |
Why?
|
Laparoscopy | 4 | 2023 | 2030 | 0.850 |
Why?
|
Oocyte Retrieval | 4 | 2021 | 160 | 0.830 |
Why?
|
Endometriosis | 5 | 2022 | 857 | 0.830 |
Why?
|
Elephants | 1 | 2022 | 41 | 0.820 |
Why?
|
Fertilization in Vitro | 13 | 2023 | 1292 | 0.790 |
Why?
|
Alkanesulfonic Acids | 4 | 2024 | 201 | 0.760 |
Why?
|
Endocrinology | 3 | 2021 | 442 | 0.760 |
Why?
|
Uterine Neoplasms | 5 | 2024 | 1420 | 0.740 |
Why?
|
Practice Management | 1 | 2021 | 37 | 0.720 |
Why?
|
Semen Analysis | 7 | 2019 | 236 | 0.710 |
Why?
|
Patient Care Team | 2 | 2021 | 2515 | 0.700 |
Why?
|
Fertility Agents, Female | 4 | 2016 | 101 | 0.700 |
Why?
|
Uterine Artery Embolization | 4 | 2024 | 59 | 0.660 |
Why?
|
Financial Management | 1 | 2021 | 160 | 0.650 |
Why?
|
Abortion, Spontaneous | 6 | 2019 | 532 | 0.650 |
Why?
|
Fluorocarbons | 4 | 2024 | 492 | 0.620 |
Why?
|
Specialization | 1 | 2023 | 778 | 0.620 |
Why?
|
Live Birth | 5 | 2019 | 510 | 0.600 |
Why?
|
Hysteroscopes | 1 | 2017 | 2 | 0.600 |
Why?
|
Phenols | 7 | 2019 | 516 | 0.600 |
Why?
|
Acetaminophen | 1 | 2021 | 555 | 0.570 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2021 | 385 | 0.570 |
Why?
|
Pregnancy | 41 | 2024 | 29868 | 0.560 |
Why?
|
Follicle Stimulating Hormone | 4 | 2019 | 726 | 0.560 |
Why?
|
Oocyte Donation | 3 | 2016 | 52 | 0.560 |
Why?
|
Gonadotropins | 3 | 2016 | 241 | 0.540 |
Why?
|
46, XX Disorders of Sex Development | 1 | 2016 | 34 | 0.530 |
Why?
|
Clomiphene | 2 | 2016 | 71 | 0.500 |
Why?
|
Surgery, Computer-Assisted | 1 | 2023 | 1002 | 0.490 |
Why?
|
Surrogate Mothers | 2 | 2008 | 16 | 0.460 |
Why?
|
Cicatrix | 1 | 2019 | 785 | 0.420 |
Why?
|
Phthalic Acids | 4 | 2020 | 478 | 0.380 |
Why?
|
Superovulation | 1 | 2010 | 11 | 0.380 |
Why?
|
Pregnancy Outcome | 9 | 2019 | 2921 | 0.370 |
Why?
|
Benzhydryl Compounds | 7 | 2019 | 915 | 0.370 |
Why?
|
Sperm Count | 5 | 2019 | 229 | 0.360 |
Why?
|
Fertility | 7 | 2024 | 769 | 0.350 |
Why?
|
Parabens | 3 | 2019 | 114 | 0.340 |
Why?
|
Benzophenones | 2 | 2020 | 57 | 0.340 |
Why?
|
Reproductive Techniques, Assisted | 6 | 2023 | 496 | 0.330 |
Why?
|
Prolactinoma | 1 | 2010 | 114 | 0.320 |
Why?
|
Hyperprolactinemia | 1 | 2010 | 124 | 0.320 |
Why?
|
Spermatozoa | 4 | 2021 | 629 | 0.320 |
Why?
|
Vagina | 3 | 2021 | 841 | 0.310 |
Why?
|
Urogenital Abnormalities | 2 | 2021 | 261 | 0.310 |
Why?
|
Maternal Exposure | 3 | 2020 | 1067 | 0.300 |
Why?
|
Semen | 3 | 2019 | 347 | 0.300 |
Why?
|
Health Personnel | 1 | 2021 | 3333 | 0.300 |
Why?
|
Female | 64 | 2024 | 392148 | 0.290 |
Why?
|
Fees and Charges | 1 | 2008 | 192 | 0.290 |
Why?
|
Endocrine Disruptors | 2 | 2020 | 264 | 0.270 |
Why?
|
Humans | 79 | 2024 | 760617 | 0.270 |
Why?
|
Reproduction | 2 | 2022 | 645 | 0.270 |
Why?
|
Marijuana Smoking | 2 | 2019 | 258 | 0.260 |
Why?
|
Embryo Transfer | 2 | 2016 | 522 | 0.260 |
Why?
|
Fellowships and Scholarships | 1 | 2014 | 1115 | 0.250 |
Why?
|
Fallopian Tube Diseases | 2 | 2023 | 60 | 0.240 |
Why?
|
Physicians | 1 | 2022 | 4583 | 0.240 |
Why?
|
Nurses | 1 | 2014 | 2477 | 0.230 |
Why?
|
Pesticide Residues | 2 | 2015 | 95 | 0.230 |
Why?
|
Terminology as Topic | 2 | 2021 | 1528 | 0.230 |
Why?
|
Blood Glucose | 4 | 2020 | 6390 | 0.230 |
Why?
|
Environmental Exposure | 4 | 2024 | 4483 | 0.230 |
Why?
|
Infertility, Male | 2 | 2019 | 396 | 0.220 |
Why?
|
Omentum | 1 | 2023 | 167 | 0.210 |
Why?
|
Sterilization | 2 | 2022 | 132 | 0.210 |
Why?
|
Fallopian Tubes | 1 | 2023 | 178 | 0.200 |
Why?
|
Polycystic Ovary Syndrome | 2 | 2024 | 376 | 0.200 |
Why?
|
Body Mass Index | 5 | 2020 | 12943 | 0.190 |
Why?
|
Pituitary Neoplasms | 1 | 2010 | 1323 | 0.190 |
Why?
|
Chorionic Gonadotropin | 2 | 2014 | 457 | 0.180 |
Why?
|
Therapies, Investigational | 1 | 2021 | 111 | 0.180 |
Why?
|
Ultrasonography, Interventional | 1 | 2008 | 1496 | 0.170 |
Why?
|
Perioperative Period | 1 | 2021 | 250 | 0.170 |
Why?
|
Ultrasonography | 3 | 2022 | 5964 | 0.170 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2022 | 284 | 0.170 |
Why?
|
Clinical Competence | 2 | 2021 | 4789 | 0.170 |
Why?
|
Soaps | 1 | 2019 | 29 | 0.170 |
Why?
|
Fruit | 2 | 2015 | 1157 | 0.170 |
Why?
|
Vegetables | 2 | 2015 | 1191 | 0.170 |
Why?
|
Clinical Coding | 1 | 2021 | 181 | 0.160 |
Why?
|
Health Occupations | 1 | 2021 | 223 | 0.160 |
Why?
|
Triclosan | 1 | 2019 | 58 | 0.160 |
Why?
|
Fertility Agents | 1 | 2018 | 11 | 0.160 |
Why?
|
Sunscreening Agents | 1 | 2019 | 139 | 0.150 |
Why?
|
Cosmetics | 1 | 2019 | 102 | 0.150 |
Why?
|
beta Carotene | 1 | 2019 | 523 | 0.150 |
Why?
|
Pregnancy, Multiple | 2 | 2016 | 215 | 0.150 |
Why?
|
Pain Measurement | 2 | 2021 | 3546 | 0.150 |
Why?
|
Device Approval | 1 | 2019 | 163 | 0.140 |
Why?
|
Fathers | 2 | 2024 | 375 | 0.140 |
Why?
|
Consensus | 2 | 2024 | 3117 | 0.140 |
Why?
|
Placebos | 1 | 2021 | 1667 | 0.140 |
Why?
|
Efficiency, Organizational | 1 | 2021 | 695 | 0.140 |
Why?
|
Adult | 34 | 2024 | 220969 | 0.140 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2021 | 463 | 0.140 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2018 | 361 | 0.140 |
Why?
|
Uterine Diseases | 1 | 2017 | 108 | 0.140 |
Why?
|
Patient Advocacy | 1 | 2019 | 360 | 0.140 |
Why?
|
Ascorbic Acid | 1 | 2019 | 655 | 0.130 |
Why?
|
Pregnancy Trimester, Second | 4 | 2020 | 730 | 0.130 |
Why?
|
Pregnancy Trimesters | 1 | 2017 | 197 | 0.130 |
Why?
|
Ovary | 2 | 2011 | 959 | 0.130 |
Why?
|
Interdisciplinary Communication | 1 | 2021 | 928 | 0.130 |
Why?
|
Climate Change | 1 | 2022 | 500 | 0.130 |
Why?
|
Estrogens, Non-Steroidal | 1 | 2015 | 52 | 0.120 |
Why?
|
Public Opinion | 1 | 2019 | 484 | 0.120 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2017 | 219 | 0.120 |
Why?
|
Pregnancy Trimester, First | 4 | 2020 | 908 | 0.120 |
Why?
|
Congenital Abnormalities | 2 | 2016 | 709 | 0.120 |
Why?
|
History, 21st Century | 1 | 2021 | 1565 | 0.120 |
Why?
|
Gallbladder Diseases | 1 | 1995 | 140 | 0.120 |
Why?
|
Medical Staff | 1 | 2014 | 40 | 0.120 |
Why?
|
Genes, Dominant | 1 | 1997 | 851 | 0.110 |
Why?
|
Ovarian Follicle | 2 | 2016 | 244 | 0.110 |
Why?
|
Self Report | 3 | 2019 | 3723 | 0.110 |
Why?
|
Treatment Outcome | 10 | 2024 | 64568 | 0.110 |
Why?
|
Decision Support Techniques | 2 | 2021 | 1998 | 0.110 |
Why?
|
Ovulation | 1 | 2014 | 181 | 0.110 |
Why?
|
Acyclovir | 1 | 1993 | 267 | 0.100 |
Why?
|
Malaria, Falciparum | 1 | 2021 | 1076 | 0.100 |
Why?
|
Massachusetts | 3 | 2021 | 8833 | 0.100 |
Why?
|
Fetus | 1 | 2020 | 1862 | 0.100 |
Why?
|
History, 20th Century | 1 | 2021 | 2764 | 0.100 |
Why?
|
Linear Models | 3 | 2024 | 5866 | 0.100 |
Why?
|
Prospective Studies | 15 | 2023 | 54360 | 0.100 |
Why?
|
Thyrotropin | 1 | 2016 | 834 | 0.100 |
Why?
|
Learning | 1 | 2021 | 1740 | 0.100 |
Why?
|
Diabetes, Gestational | 2 | 2019 | 1250 | 0.100 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2014 | 393 | 0.100 |
Why?
|
Pelvic Pain | 1 | 2014 | 292 | 0.100 |
Why?
|
Premature Birth | 1 | 2024 | 1782 | 0.100 |
Why?
|
Age Factors | 3 | 2020 | 18381 | 0.100 |
Why?
|
Oocytes | 2 | 2016 | 1166 | 0.100 |
Why?
|
Quality Assurance, Health Care | 1 | 2021 | 2164 | 0.090 |
Why?
|
Male | 23 | 2024 | 360358 | 0.090 |
Why?
|
Herpes Zoster | 1 | 1993 | 253 | 0.090 |
Why?
|
Pain, Postoperative | 1 | 2021 | 1737 | 0.090 |
Why?
|
Exercise | 2 | 2020 | 5886 | 0.090 |
Why?
|
Primary Ovarian Insufficiency | 1 | 2011 | 107 | 0.090 |
Why?
|
United States Food and Drug Administration | 1 | 2019 | 1661 | 0.090 |
Why?
|
Dairy Products | 1 | 2014 | 490 | 0.090 |
Why?
|
Follicular Phase | 1 | 2010 | 143 | 0.090 |
Why?
|
Embryo Implantation | 1 | 2012 | 270 | 0.090 |
Why?
|
Cesarean Section | 1 | 2019 | 1396 | 0.090 |
Why?
|
Diet | 3 | 2024 | 8048 | 0.090 |
Why?
|
Syndrome | 1 | 2016 | 3268 | 0.090 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 1993 | 662 | 0.090 |
Why?
|
Obesity | 2 | 2012 | 12933 | 0.080 |
Why?
|
Menorrhagia | 1 | 2009 | 59 | 0.080 |
Why?
|
Abnormalities, Multiple | 1 | 2016 | 1422 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 2 | 2021 | 36402 | 0.080 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2021 | 3356 | 0.080 |
Why?
|
Retrospective Studies | 8 | 2016 | 80566 | 0.080 |
Why?
|
Point-of-Care Systems | 1 | 2017 | 1213 | 0.080 |
Why?
|
Prolactin | 1 | 2010 | 625 | 0.070 |
Why?
|
Hysterectomy | 2 | 2023 | 856 | 0.070 |
Why?
|
Emotions | 1 | 2019 | 2740 | 0.070 |
Why?
|
Uterine Hemorrhage | 1 | 2009 | 240 | 0.070 |
Why?
|
Double-Blind Method | 1 | 2021 | 12334 | 0.070 |
Why?
|
Leptin | 2 | 2007 | 1595 | 0.070 |
Why?
|
Patient Satisfaction | 1 | 2019 | 3451 | 0.070 |
Why?
|
Quality of Life | 3 | 2023 | 13347 | 0.070 |
Why?
|
Young Adult | 7 | 2024 | 59179 | 0.070 |
Why?
|
Motor Cortex | 1 | 2014 | 1007 | 0.070 |
Why?
|
Dietary Fats | 1 | 2014 | 1995 | 0.070 |
Why?
|
Biomedical Research | 1 | 2021 | 3426 | 0.070 |
Why?
|
Birth Rate | 2 | 2019 | 168 | 0.070 |
Why?
|
Cohort Studies | 7 | 2019 | 41457 | 0.060 |
Why?
|
Faculty, Medical | 1 | 2014 | 1204 | 0.060 |
Why?
|
Pregnancy Complications | 2 | 2019 | 2948 | 0.060 |
Why?
|
Placenta Accreta | 1 | 2009 | 237 | 0.060 |
Why?
|
Sperm Motility | 2 | 2019 | 266 | 0.060 |
Why?
|
Postpartum Hemorrhage | 1 | 2009 | 272 | 0.060 |
Why?
|
Boston | 4 | 2020 | 9313 | 0.060 |
Why?
|
Risk Factors | 5 | 2024 | 74115 | 0.060 |
Why?
|
Sulfonic Acids | 1 | 2024 | 103 | 0.060 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2014 | 3769 | 0.060 |
Why?
|
Body Weight | 2 | 2012 | 4614 | 0.050 |
Why?
|
Hysterosalpingography | 1 | 2023 | 26 | 0.050 |
Why?
|
Attitude to Health | 1 | 2012 | 2024 | 0.050 |
Why?
|
Spasm | 1 | 2023 | 130 | 0.050 |
Why?
|
Logistic Models | 2 | 2014 | 13245 | 0.050 |
Why?
|
Triiodothyronine | 1 | 2024 | 493 | 0.050 |
Why?
|
Radiography, Interventional | 1 | 2009 | 1120 | 0.050 |
Why?
|
Bayes Theorem | 2 | 2020 | 2326 | 0.050 |
Why?
|
Pregnancy Complications, Infectious | 1 | 1993 | 2149 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5430 | 0.050 |
Why?
|
Thyroid Hormones | 1 | 2024 | 403 | 0.050 |
Why?
|
Weight Loss | 1 | 2012 | 2682 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12043 | 0.040 |
Why?
|
Healthcare Disparities | 1 | 2016 | 3351 | 0.040 |
Why?
|
Time-Lapse Imaging | 1 | 2021 | 194 | 0.040 |
Why?
|
Endometrium | 1 | 2003 | 403 | 0.040 |
Why?
|
Histocytochemistry | 1 | 2021 | 696 | 0.040 |
Why?
|
Academic Medical Centers | 3 | 2016 | 2756 | 0.040 |
Why?
|
Risk Assessment | 2 | 2019 | 23972 | 0.040 |
Why?
|
United States | 3 | 2024 | 72272 | 0.040 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 1 | 2019 | 81 | 0.040 |
Why?
|
Embolization, Therapeutic | 1 | 2009 | 1418 | 0.040 |
Why?
|
Interleukin-1 | 1 | 2003 | 1248 | 0.040 |
Why?
|
Adolescent | 4 | 2021 | 88234 | 0.040 |
Why?
|
Sperm Injections, Intracytoplasmic | 1 | 2019 | 156 | 0.040 |
Why?
|
Radiography | 1 | 2010 | 6961 | 0.040 |
Why?
|
Infant, Newborn | 4 | 2024 | 26180 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39063 | 0.040 |
Why?
|
Spermatogenesis | 1 | 2019 | 258 | 0.040 |
Why?
|
Cervix Uteri | 1 | 2021 | 570 | 0.040 |
Why?
|
Video Recording | 1 | 2023 | 965 | 0.040 |
Why?
|
Pregnancy Trimester, Third | 1 | 2020 | 582 | 0.040 |
Why?
|
Thyroid Gland | 1 | 2024 | 1170 | 0.040 |
Why?
|
Hearing Disorders | 1 | 1997 | 126 | 0.030 |
Why?
|
Immunoglobulins, Thyroid-Stimulating | 1 | 2016 | 34 | 0.030 |
Why?
|
Internet | 1 | 2008 | 3090 | 0.030 |
Why?
|
Prevalence | 2 | 2011 | 15689 | 0.030 |
Why?
|
Comprehension | 1 | 2021 | 620 | 0.030 |
Why?
|
Microscopy | 1 | 2021 | 905 | 0.030 |
Why?
|
Pregnant Women | 1 | 2020 | 567 | 0.030 |
Why?
|
Birth Weight | 1 | 2024 | 2101 | 0.030 |
Why?
|
Embryo, Mammalian | 1 | 2021 | 1670 | 0.030 |
Why?
|
Animals | 3 | 2024 | 168201 | 0.030 |
Why?
|
Rupture, Spontaneous | 1 | 1995 | 362 | 0.030 |
Why?
|
Sexual Partners | 1 | 2019 | 800 | 0.030 |
Why?
|
Information Dissemination | 1 | 2023 | 1125 | 0.030 |
Why?
|
Menotropins | 1 | 2014 | 41 | 0.030 |
Why?
|
Ear, Middle | 1 | 1997 | 339 | 0.030 |
Why?
|
Seasons | 1 | 2020 | 1518 | 0.030 |
Why?
|
Prognosis | 1 | 2014 | 29600 | 0.030 |
Why?
|
Leadership | 1 | 2022 | 1385 | 0.030 |
Why?
|
Middle Aged | 8 | 2020 | 220584 | 0.030 |
Why?
|
Puerperal Disorders | 1 | 1995 | 300 | 0.030 |
Why?
|
Cryopreservation | 1 | 2017 | 728 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 26049 | 0.020 |
Why?
|
Antioxidants | 1 | 2019 | 1668 | 0.020 |
Why?
|
Diet, Fat-Restricted | 1 | 2014 | 329 | 0.020 |
Why?
|
Plasmodium falciparum | 1 | 2021 | 1740 | 0.020 |
Why?
|
Ambulatory Care Facilities | 1 | 2017 | 934 | 0.020 |
Why?
|
Fragile X Mental Retardation Protein | 1 | 2011 | 115 | 0.020 |
Why?
|
Environmental Monitoring | 1 | 2017 | 1460 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2019 | 14591 | 0.020 |
Why?
|
Fragile X Syndrome | 1 | 2011 | 116 | 0.020 |
Why?
|
Pilot Projects | 1 | 2023 | 8618 | 0.020 |
Why?
|
Family Characteristics | 1 | 2014 | 992 | 0.020 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2011 | 783 | 0.020 |
Why?
|
Public Health | 1 | 2022 | 2669 | 0.020 |
Why?
|
Placentation | 1 | 2009 | 78 | 0.020 |
Why?
|
Balloon Occlusion | 1 | 2009 | 125 | 0.020 |
Why?
|
Electric Stimulation Therapy | 1 | 2014 | 626 | 0.020 |
Why?
|
Angiography, Digital Subtraction | 1 | 2009 | 335 | 0.020 |
Why?
|
Iliac Artery | 1 | 2009 | 343 | 0.020 |
Why?
|
Research Design | 1 | 2023 | 6174 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2019 | 3411 | 0.020 |
Why?
|
Registries | 1 | 2023 | 8207 | 0.020 |
Why?
|
Time Factors | 3 | 2016 | 39913 | 0.020 |
Why?
|
Pain | 1 | 2021 | 5061 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10548 | 0.020 |
Why?
|
Catheterization, Peripheral | 1 | 2009 | 343 | 0.020 |
Why?
|
Emergency Treatment | 1 | 2009 | 495 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15251 | 0.020 |
Why?
|
Signal Transduction | 1 | 2007 | 23416 | 0.010 |
Why?
|
Integrin beta3 | 1 | 2003 | 120 | 0.010 |
Why?
|
Estradiol | 1 | 2009 | 1937 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2007 | 2063 | 0.010 |
Why?
|
Sialoglycoproteins | 1 | 2003 | 315 | 0.010 |
Why?
|
Receptors, Interleukin-1 | 1 | 2003 | 262 | 0.010 |
Why?
|
Odds Ratio | 1 | 2014 | 9643 | 0.010 |
Why?
|
Receptors, Leptin | 1 | 2003 | 350 | 0.010 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2003 | 299 | 0.010 |
Why?
|
Overweight | 1 | 2012 | 2417 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 8516 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2007 | 2644 | 0.010 |
Why?
|
Child | 1 | 2024 | 80079 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2007 | 9529 | 0.010 |
Why?
|
Antibodies | 1 | 2003 | 2414 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2003 | 2802 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14648 | 0.010 |
Why?
|
Phenotype | 1 | 2007 | 16571 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2007 | 22115 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2007 | 18221 | 0.000 |
Why?
|
Cells, Cultured | 1 | 2003 | 18937 | 0.000 |
Why?
|
Mice | 1 | 2007 | 81368 | 0.000 |
Why?
|